Abstract

There is an increasing interest in the measurement of nitric oxide (NO ) in the airways. NO is a free radical that reacts rapidly with reactive oxygen species in aqueous solution to form peroxynitrite which can then break down to nitrite (NO 2 −) and nitrate (NO 3 −). NO 3 − is considered a stable oxidative end product of NO metabolism. The aim of this study was to assay NO 3 − in exhaled breath condensate (EBC) of normal nonsmoking and smoking subjects, asthmatics, patients with obstructive pulmonary disease (COPD), and patients with community-acquired pneumonia (CAP). EBC was collected using a glass condenser and samples were assayed for NO 3 − by ion chromatography followed by conductivity measurement. NO 3 − was detectable in EBC of all subjects. NO 3 − was elevated in smokers [median (range)] [62.5 (9.6–158.0) μM] and in asthmatics [68.0 (25.8–194.6) μM] compared to controls [9.6 (2.6–119.4) μM; p=0.003 and p=0.006, respectively], whereas NO 3 − was not elevated in COPD patients [24.1 (1.9–337.0) μM]. The concentration of NO 3 − in patients with CAP [243.4 (26.1–584.5) μM] was higher than that in controls ( p=0.002) and NO 3 − values decreased after treatment and recovery from illness [40.0 (4.1–167.0) μM, p=0.009]. This study shows that NO 3 − is detectable in EBC of healthy subjects and it varies in patients with inflammatory airway diseases.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.